More than twenty years ago, genetic screening for dyslipidemia was restricted to FH by Sanger sequencing of the LDLR promoter and coding region and exon 26 and 29 of APOB, the only two APOB regions known for pathogenic FH variants. This evidence concerns the gene APOB and metabolic syndrome.